Gregory A. Poland - Publications

Affiliations: 
Vaccine Research Group Mayo Clinic, Rochester, MN, United States 

285 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Quach HQ, Goergen KM, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB. Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation. Frontiers in Immunology. 14: 1168784. PMID 37600811 DOI: 10.3389/fimmu.2023.1168784  0.836
2023 Poland GA, Kennedy RB. The use of AI-generated text and scientific publishing: Issues and a way forward. Vaccine. 41: 4065-4066. PMID 37336615 DOI: 10.1016/j.vaccine.2023.06.010  0.42
2023 Ovsyannikova IG, Haralambieva IH, Schaid DJ, Warner ND, Poland GA, Kennedy RB. Genome-Wide Determinants of Cellular Immune Responses to Mumps Vaccine. Medrxiv : the Preprint Server For Health Sciences. PMID 37205333 DOI: 10.1101/2023.04.27.23289213  0.825
2022 Haralambieva IH, Quach HQ, Ovsyannikova IG, Goergen KM, Grill DE, Poland GA, Kennedy RB. T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults. Viruses. 14. PMID 36560767 DOI: 10.3390/v14122763  0.823
2022 Quach HQ, Ovsyannikova IG, Grill DE, Warner ND, Poland GA, Kennedy RB. Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population. Vaccines. 10. PMID 36366367 DOI: 10.3390/vaccines10111859  0.823
2022 Poland GA, Kennedy RB, Tosh PK. Prevention of monkeypox with vaccines: a rapid review. The Lancet. Infectious Diseases. PMID 36116460 DOI: 10.1016/S1473-3099(22)00574-6  0.768
2022 Moore KA, Osterholm MT, Lackritz EM, Poland GA. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats. Vaccine. PMID 36109277 DOI: 10.1016/j.vaccine.2022.08.071  0.394
2022 Quach HQ, Ovsyannikova IG, Poland GA, Kennedy RB. Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine. Scientific Reports. 12: 15401. PMID 36100624 DOI: 10.1038/s41598-022-19679-3  0.767
2022 Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschöpe C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, et al. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. European Journal of Heart Failure. PMID 36065751 DOI: 10.1002/ejhf.2669  0.369
2022 Quach HQ, Chen J, Monroe JM, Ratishvili T, Warner ND, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB. The influence of sex, BMI, and age on cellular and humoral immune responses against measles after a 3rd dose of MMR vaccine. The Journal of Infectious Diseases. PMID 35994504 DOI: 10.1093/infdis/jiac351  0.817
2022 Luo C, Du J, Cuker A, Lautenbach E, Asch DA, Poland GA, Tao C, Chen Y. Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety. Scientific Reports. 12: 10946. PMID 35768434 DOI: 10.1038/s41598-022-13809-7  0.525
2022 Top KA, Chen RT, Levy O, Ozonoff A, Carleton B, Crawford N, Buddy Creech C, Kochhar S, Poland GA, Gutu K, Cutland CL. Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35680552 DOI: 10.1093/cid/ciac407  0.561
2022 Quach HQ, Ovsyannikova IG, Poland GA, Kennedy RB. Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA. Journal of Immunological Methods. 505: 113275. PMID 35439529 DOI: 10.1016/j.jim.2022.113275  0.697
2022 Poland GA, Kennedy RB. Vaccine safety in an era of novel vaccines: a proposed research agenda. Nature Reviews. Immunology. PMID 35197577 DOI: 10.1038/s41577-022-00695-3  0.716
2022 Haralambieva IH, Monroe JM, Ovsyannikova IG, Grill DE, Poland GA, Kennedy RB. Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time after SARS-CoV-2 mRNA Vaccination. The Journal of Infectious Diseases. PMID 35137144 DOI: 10.1093/infdis/jiac042  0.821
2021 Riggenbach MM, Haralambieva IH, Ovsyannikova IG, Schaid DJ, Poland GA, Kennedy RB. Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents. Clinical Immunology (Orlando, Fla.). 234: 108912. PMID 34968746 DOI: 10.1016/j.clim.2021.108912  0.806
2021 Kennedy RB, Ovsyannikova IG, Haralambieva IH, Grill DE, Poland GA. Proteomic assessment of humoral immune responses in smallpox vaccine recipients. Vaccine. 40: 789-797. PMID 34952760 DOI: 10.1016/j.vaccine.2021.12.033  0.829
2021 Ali A, Dwyer D, Wu Q, Wang Q, Dowling CA, Fox DA, Khanna D, Poland GA, Mao-Draayer Y. Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies. Vaccine. PMID 34483021 DOI: 10.1016/j.vaccine.2021.08.078  0.502
2021 Kennedy RB, Ovsyannikova IG, Poland G. Update on Influenza Vaccines: Needs and Progress. The Journal of Allergy and Clinical Immunology. in Practice. PMID 34416408 DOI: 10.1016/j.jaip.2021.08.003  0.807
2021 Janssen RS, Bruxvoort K, Jacobsen SJ, Slezak J, David C, Hyer R, Poland GA. Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination. Vaccine. PMID 34404556 DOI: 10.1016/j.vaccine.2021.07.100  0.469
2021 Poland GA, Ovsyannikova IG, Kennedy RB. The need for broadly protective COVID-19 vaccines: Beyond S-only approaches. Vaccine. PMID 34167836 DOI: 10.1016/j.vaccine.2021.06.028  0.791
2021 Poland GA, Ovsyannikova IG, Kennedy RB. Pharmacogenomics and Vaccine Development. Clinical Pharmacology and Therapeutics. PMID 34097754 DOI: 10.1002/cpt.2288  0.811
2021 Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA. Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects. Plos One. 16: e0252198. PMID 34077451 DOI: 10.1371/journal.pone.0252198  0.775
2021 Haralambieva IH, Eberhard KG, Ovsyannikova IG, Grill DE, Schaid DJ, Kennedy RB, Poland GA. Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age. European Journal of Immunology. PMID 33818775 DOI: 10.1002/eji.202049054  0.834
2021 Axelsen PH, Poland GA. Vaccines, masks, distancing and credibility: An urgent warning for pandemic management. Vaccine. PMID 33536137 DOI: 10.1016/j.vaccine.2021.01.052  0.478
2021 Luo C, Jiang Y, Du J, Tong J, Huang J, Lo Re V, Ellenberg SS, Poland GA, Tao C, Chen Y. Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system. Pharmacoepidemiology and Drug Safety. PMID 33533072 DOI: 10.1002/pds.5196  0.52
2021 Whitaker JA, Parikh SA, Shanafelt TD, Kay NE, Kennedy RB, Grill DE, Goergen KM, Call TG, Kendarian SS, Ding W, Poland GA. The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine. PMID 33461835 DOI: 10.1016/j.vaccine.2021.01.001  0.699
2021 Jacobson RM, Ovsyannikova IG, Poland GA. Genetic basis for variation of vaccine response: our studies with rubella vaccine. Paediatrics & Child Health. 19: S156-S159. PMID 20976024 DOI: 10.1016/j.paed.2009.08.019  0.79
2020 Crooke SN, Riggenbach MM, Ovsyannikova IG, Warner ND, Chen MH, Hao L, Icenogle JP, Poland GA, Kennedy RB. Durability of humoral immune responses to rubella following MMR vaccination. Vaccine. PMID 33190948 DOI: 10.1016/j.vaccine.2020.10.076  0.824
2020 Du J, Luo C, Shegog R, Bian J, Cunningham RM, Boom JA, Poland GA, Chen Y, Tao C. Use of Deep Learning to Analyze Social Media Discussions About the Human Papillomavirus Vaccine. Jama Network Open. 3: e2022025. PMID 33185676 DOI: 10.1001/jamanetworkopen.2020.22025  0.428
2020 Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, Borio L, Brewer J, Buccina J, Connell N, Hall LL, Kass N, Kirkland A, Koonin L, Larson H, ... ... Poland GA, et al. The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. PMID 33160755 DOI: 10.1016/j.vaccine.2020.10.059  0.545
2020 Crooke SN, Ovsyannikova IG, Kennedy RB, Warner ND, Poland GA. Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine. Vaccine. PMID 33158591 DOI: 10.1016/j.vaccine.2020.10.071  0.819
2020 Kennedy RB, Haralambieva IH, Ovsyannikova IG, Voigt EA, Larrabee BR, Schaid DJ, Zimmermann MT, Oberg AL, Poland GA. Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses. Frontiers in Immunology. 11: 567348. PMID 33154747 DOI: 10.3389/fimmu.2020.567348  0.768
2020 Corder BN, Bullard BL, Poland GA, Weaver EA. A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade. Viruses. 12. PMID 33092070 DOI: 10.3390/v12101186  0.51
2020 Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet (London, England). PMID 33065034 DOI: 10.1016/S0140-6736(20)32137-1  0.795
2020 Poland GA, Ovsyannikova IG, Crooke SN, Kennedy RB. SARS-CoV-2 Vaccine Development: Current Status. Mayo Clinic Proceedings. 95: 2172-2188. PMID 33012348 DOI: 10.1016/j.mayocp.2020.07.021  0.821
2020 Crooke SN, Haralambieva IH, Grill DE, Ovsyannikova IG, Kennedy RB, Poland GA. Corrigendum to "Seroprevalence and durability of rubella virus antibodies in a highly immunized population". [Vaccine 37 (2019) 3876-3882]. Vaccine. PMID 32950302 DOI: 10.1016/j.vaccine.2020.09.026  0.809
2020 Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Scientific Reports. 10: 14179. PMID 32843695 DOI: 10.1038/s41598-020-70864-8  0.775
2020 Privor-Dumm LA, Poland GA, Barratt J, Durrheim DN, Knoll MD, Vasudevan P, Jit M, Bonvehí PE, Bonanni P. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine. PMID 32703743 DOI: 10.1016/J.Vaccine.2020.06.082  0.442
2020 Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Frontiers in Immunology. 11: 1181. PMID 32670279 DOI: 10.3389/Fimmu.2020.01181  0.812
2020 Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunological Reviews. PMID 32658335 DOI: 10.1111/imr.12897  0.691
2019 Poland GA, Ovsyannikova IG, Kennedy RB. Zika Vaccine Development: Current Status. Mayo Clinic Proceedings. 94: 2572-2586. PMID 31806107 DOI: 10.1016/j.mayocp.2019.05.016  0.808
2019 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Goergen KM, Grill DE, Chen MH, Hao L, Icenogle J, Poland GA. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age. Vaccine. PMID 31732325 DOI: 10.1016/j.vaccine.2019.11.004  0.809
2019 Maltezou HC, Botelho-Nevers E, Brantsæter AB, Carlsson RM, Heininger U, Hübschen JM, Josefsdottir KS, Kassianos G, Kyncl J, Ledda C, Medić S, Nitsch-Osuch A, de Lejarazu RO, Theodoridou M, Van Damme P, ... ... Poland GA, et al. Vaccination of healthcare personnel in Europe: Update to current policies. Vaccine. PMID 31623916 DOI: 10.1016/j.vaccine.2019.09.061  0.504
2019 Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immunity & Ageing : I & A. 16: 25. PMID 31528180 DOI: 10.1186/s12979-019-0164-9  0.828
2019 Zimmermann MT, Kabat B, Grill DE, Kennedy RB, Poland GA. RITAN: rapid integration of term annotation and network resources. Peerj. 7: e6994. PMID 31355053 DOI: 10.7717/Peerj.6994  0.435
2019 Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses. Experimental Gerontology. 124: 110632. PMID 31201918 DOI: 10.1016/j.exger.2019.110632  0.82
2019 Crooke SN, Haralambieva IH, Grill DE, Ovsyannikova IG, Kennedy RB, Poland GA. Seroprevalence and durability of rubella virus antibodies in a highly immunized population. Vaccine. PMID 31126859 DOI: 10.1016/j.vaccine.2019.05.049  0.816
2019 Voigt EA, Ovsyannikova IG, Kennedy RB, Grill DE, Goergen KM, Schaid DJ, Poland GA. Sex Differences in Older Adults' Immune Responses to Seasonal Influenza Vaccination. Frontiers in Immunology. 10: 180. PMID 30873150 DOI: 10.3389/Fimmu.2019.00180  0.794
2019 Kennedy RB, Ovsyannikova IG, Thomas A, Larrabee BR, Rubin S, Poland GA. Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine. PMID 30797639 DOI: 10.1016/j.vaccine.2019.02.030  0.838
2019 Pezeshki A, Ovsyannikova IG, McKinney BA, Poland GA, Kennedy RB. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines. Expert Review of Vaccines. PMID 30700167 DOI: 10.1080/14760584.2019.1575208  0.823
2018 Haralambieva IH, Kennedy RB, Ovsyannikova IG, Schaid DJ, Poland GA. Current perspectives in assessing humoral immunity after measles vaccination. Expert Review of Vaccines. 18: 75-87. PMID 30585753 DOI: 10.1080/14760584.2019.1559063  0.834
2018 Muhsen IN, Aljurf M, Wingard JR, Poland GA, Komanduri KV, Whitaker JA, Hashmi SK. Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives. Vaccine. 36: 6043-6052. PMID 30195488 DOI: 10.1016/j.vaccine.2018.08.044  0.442
2018 Esposito S, Principi N, Rezza G, Bonanni P, Gavazzi G, Beyer I, Sulzner M, Celentano LP, Prymula R, Rappagliosi A, Sevilla J, Poland G. Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward. Vaccine. PMID 30143273 DOI: 10.1016/j.vaccine.2018.08.041  0.418
2018 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Poland GA. Detection and Quantification of Influenza A/H1N1 Virus-Specific Memory B Cells in Human PBMCs Using ELISpot Assay. Methods in Molecular Biology (Clifton, N.J.). 1808: 221-236. PMID 29956187 DOI: 10.1007/978-1-4939-8567-8_19  0.788
2018 Poland GA, Kennedy RB, Ovsyannikova IG, Palacios R, Ho PL, Kalil J. Development of vaccines against Zika virus. The Lancet. Infectious Diseases. PMID 29396004 DOI: 10.1016/S1473-3099(18)30063-X  0.775
2018 Haralambieva IH, Kennedy RB, Simon WL, Goergen KM, Grill DE, Ovsyannikova IG, Poland GA. Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination. Plos One. 13: e0191812. PMID 29381765 DOI: 10.1371/journal.pone.0191812  0.789
2018 Teresa Aguado M, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, Friede M, Ortiz JR. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine. PMID 29336923 DOI: 10.1016/J.Vaccine.2017.12.029  0.36
2018 Voigt EA, Grill DE, Zimmermann MT, Simon WL, Ovsyannikova IG, Kennedy RB, Poland GA. Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering. Scientific Reports. 8: 739. PMID 29335477 DOI: 10.1038/S41598-017-17735-X  0.809
2017 Voigt EA, Haralambieva IH, Larrabee BL, Kennedy RB, Ovsyannikova IG, Schaid DJ, Poland GA. Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination. The Journal of Infectious Diseases. PMID 29253144 DOI: 10.1093/Infdis/Jix538  0.823
2017 Haralambieva IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, Warner ND, Grill DE, Poland GA. Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology. Plos One. 12: e0188149. PMID 29145521 DOI: 10.1371/journal.pone.0188149  0.79
2017 Zimmermann MT, Kennedy RB, Grill DE, Oberg AL, Goergen KM, Ovsyannikova IG, Haralambieva IH, Poland GA. Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations. Frontiers in Immunology. 8: 445. PMID 28484452 DOI: 10.3389/Fimmu.2017.00445  0.816
2017 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Zimmermann MT, Grill DE, Schaid DJ, Poland GA. Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. Human Genetics. PMID 28289848 DOI: 10.1007/S00439-017-1768-9  0.775
2017 Ovsyannikova IG, Larrabee BR, Schaid DJ, Poland GA. Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity. Vaccine. 35: 5444-5447. PMID 28274637 DOI: 10.1016/j.vaccine.2017.02.046  0.761
2017 Schaid DJ, Haralambieva IH, Larrabee BR, Ovsyannikova IG, Kennedy RB, Poland GA. Heritability of vaccine-induced measles neutralizing antibody titers. Vaccine. PMID 28189400 DOI: 10.1016/j.vaccine.2017.01.078  0.791
2017 Ovsyannikova IG, Schaid DJ, Larrabee BR, Haralambieva IH, Kennedy RB, Poland GA. A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses. Plos One. 12: e0171261. PMID 28158231 DOI: 10.1371/journal.pone.0171261  0.807
2017 Sadarangani SP, Ovsyannikova IG, Goergen K, Grill DE, Poland GA. Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons. Human Vaccines & Immunotherapeutics. 12: 691-8. PMID 26575832 DOI: 10.1080/21645515.2015.1097015  0.726
2016 Choung RS, Larson SA, Khaleghi S, Rubio-Tapia A, Ovsyannikova IG, King KS, Larson JJ, Lahr BD, Poland GA, Camilleri MJ, Murray JA. Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-based Study. Gastroenterology. PMID 27916669 DOI: 10.1053/j.gastro.2016.11.043  0.454
2016 Kennedy RB, Ovsyannikova IG, Haralambieva IH, Oberg AL, Zimmermann MT, Grill DE, Poland GA. Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination. Frontiers in Immunology. 7: 450. PMID 27853459 DOI: 10.3389/Fimmu.2016.00450  0.752
2016 Salk HM, Simon WL, Lambert ND, Kennedy RB, Grill DE, Kabat BF, Poland GA. Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine. Plos One. 11: e0162803. PMID 27643883 DOI: 10.1371/journal.pone.0162803  0.675
2016 Voigt EA, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Larrabee BR, Schaid DJ, Poland GA. Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination. Vaccine. PMID 27591105 DOI: 10.1016/J.Vaccine.2016.08.060  0.832
2016 Haralambieva IH, Zimmermann MT, Ovsyannikova IG, Grill DE, Oberg AL, Kennedy RB, Poland GA. Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination. Plos One. 11: e0160970. PMID 27529750 DOI: 10.1371/Journal.Pone.0160970  0.791
2016 Schaid DJ, Tong X, Larrabee B, Kennedy RB, Poland GA, Sinnwell JP. Statistical Methods for Testing Genetic Pleiotropy. Genetics. PMID 27527515 DOI: 10.1534/genetics.116.189308  0.525
2016 McKinney BA, Lareau C, Oberg AL, Kennedy RB, Ovsyannikova IG, Poland GA. The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine. Plos One. 11: e0158016. PMID 27513748 DOI: 10.1371/journal.pone.0158016  0.728
2016 Ovsyannikova IG, Oberg AL, Kennedy RB, Zimmermann MT, Haralambieva IH, Goergen KM, Grill DE, Poland GA. Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals. Heliyon. 2: e00098. PMID 27441275 DOI: 10.1016/J.Heliyon.2016.E00098  0.815
2016 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Zimmermann MT, Grill DE, Oberg AL, Poland GA. Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals. Vaccine. PMID 27317456 DOI: 10.1016/J.Vaccine.2016.06.034  0.726
2016 Rahmani B, Zimmermann MT, Grill DE, Kennedy RB, Oberg AL, White BC, Poland GA, McKinney BA. Recursive Indirect-Paths Modularity (RIP-M) for Detecting Community Structure in RNA-Seq Co-expression Networks. Frontiers in Genetics. 7: 80. PMID 27242890 DOI: 10.3389/Fgene.2016.00080  0.495
2016 Kennedy RB, Simon WL, Gibson MJ, Goergen KM, Grill DE, Oberg AL, Poland GA. The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults. Immunology. PMID 27188667 DOI: 10.1111/imm.12599  0.719
2016 Kennedy RB, Poland GA, Ovsyannikova IG, Oberg AL, Asmann YW, Grill DE, Vierkant RA, Jacobson RM. Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients. Vaccine. PMID 27177944 DOI: 10.1016/J.Vaccine.2016.05.005  0.848
2016 Rubin S, Kennedy R, Poland G. Emerging mumps infection. The Pediatric Infectious Disease Journal. PMID 27097351 DOI: 10.1097/INF.0000000000001182  0.434
2016 Voigt EA, Kennedy RB, Poland GA. Defending Against Smallpox: a Focus on Vaccines. Expert Review of Vaccines. PMID 27049653 DOI: 10.1080/14760584.2016.1175305  0.707
2016 Poland GA, Whitaker JA, Poland CM, Ovsyannikova IG, Kennedy RB. Vaccinology in the third millennium: scientific and social challenges. Current Opinion in Virology. 17: 116-25. PMID 27039875 DOI: 10.1016/j.coviro.2016.03.003  0.808
2016 Zimmermann MT, Oberg AL, Grill DE, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Poland GA. System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination. Plos One. 11: e0152034. PMID 27031986 DOI: 10.1371/Journal.Pone.0152034  0.789
2016 Palacios R, Poland GA, Kalil J. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus. Vaccine. 34: 2291-3. PMID 27015734 DOI: 10.1016/j.vaccine.2016.03.059  0.465
2016 Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, ... Poland GA, et al. Humoral and Cell Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans. Clinical and Vaccine Immunology : Cvi. PMID 26865594 DOI: 10.1128/Cvi.00696-15  0.412
2015 Laniosz V, Lehman JS, Poland GA, Wetter DA. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses. International Journal of Dermatology. PMID 26711431 DOI: 10.1111/ijd.13140  0.55
2015 Haralambieva IH, Kennedy RB, Ovsyannikova IG, Whitaker JA, Poland GA. Variability in Humoral Immunity to Measles Vaccine: New Developments. Trends in Molecular Medicine. PMID 26602762 DOI: 10.1016/j.molmed.2015.10.005  0.823
2015 Ovsyannikova IG, Salk HM, Larrabee BR, Pankratz VS, Poland GA. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children. Immunogenetics. 67: 547-61. PMID 26329766 DOI: 10.1007/s00251-015-0864-z  0.72
2015 Sadarangani SP, Whitaker JA, Poland GA. "Let there be light": the role of vitamin D in the immune response to vaccines. Expert Review of Vaccines. 14: 1427-40. PMID 26325349 DOI: 10.1586/14760584.2015.1082426  0.308
2015 Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 33: 4422-9. PMID 26163925 DOI: 10.1016/j.vaccine.2015.06.101  0.709
2015 Kennedy RB, Tosh PK, Goergen KM, Grill DE, Oberg AL, Poland GA. Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults. Vaccine. 33: 3682-8. PMID 26087295 DOI: 10.1016/j.vaccine.2015.06.031  0.714
2015 Oberg AL, McKinney BA, Schaid DJ, Pankratz VS, Kennedy RB, Poland GA. Lessons learned in the analysis of high-dimensional data in vaccinomics. Vaccine. 33: 5262-70. PMID 25957070 DOI: 10.1016/j.vaccine.2015.04.088  0.682
2015 Chen W, Larrabee BR, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Poland GA, Schaid DJ. Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics. Genetics. 200: 719-36. PMID 25948564 DOI: 10.1534/genetics.115.176107  0.616
2015 Whitaker JA, Ovsyannikova IG, Poland GA. Adversomics: a new paradigm for vaccine safety and design. Expert Review of Vaccines. 14: 935-47. PMID 25937189 DOI: 10.1586/14760584.2015.1038249  0.731
2015 Jacobson RM, Grill DE, Oberg AL, Tosh PK, Ovsyannikova IG, Poland GA. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers. Human Vaccines & Immunotherapeutics. 11: 961-9. PMID 25835513 DOI: 10.1080/21645515.2015.1011990  0.728
2015 Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, Oberg AL, Poland GA. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects. Plos One. 10: e0122282. PMID 25816015 DOI: 10.1371/journal.pone.0122282  0.807
2015 Haralambieva IH, Simon WL, Kennedy RB, Ovsyannikova IG, Warner ND, Grill DE, Poland GA. Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays. Viruses. 7: 1113-33. PMID 25763865 DOI: 10.3390/v7031113  0.836
2015 Russell KL, Baker CI, Hansen C, Poland GA, Ryan MA, Merrill MM, Gray GC. Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial. Vaccine. 33: 1182-7. PMID 25579777 DOI: 10.1016/J.Vaccine.2014.12.058  0.455
2015 Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. The Journal of Infectious Diseases. 211: 898-905. PMID 25293367 DOI: 10.1093/infdis/jiu553  0.828
2014 Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA. Cytokine production associated with smallpox vaccine responses. Immunotherapy. 6: 1097-112. PMID 25428648 DOI: 10.2217/imt.14.72  0.829
2014 Whitaker JA, Shanafelt TD, Poland GA, Kay NE. Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia. Clinical Advances in Hematology & Oncology : H&O. 12: 440-50. PMID 25322324  0.535
2014 Ovsyannikova IG, Salk HM, Larrabee BR, Pankratz VS, Poland GA. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines. Immunogenetics. 66: 663-9. PMID 25139337 DOI: 10.1007/s00251-014-0796-z  0.717
2014 Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination. Human Genetics. 133: 1407-17. PMID 25098560 DOI: 10.1007/s00439-014-1471-z  0.825
2014 Whitaker JA, Poland GA. Measles and mumps outbreaks in the United States: Think globally, vaccinate locally Vaccine. 32: 4703-4704. PMID 24992719 DOI: 10.1016/j.vaccine.2014.06.088  0.44
2014 Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. Plos One. 9: e99997. PMID 24945853 DOI: 10.1371/journal.pone.0099997  0.797
2014 Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Human Genetics. 133: 1083-92. PMID 24880604 DOI: 10.1007/s00439-014-1449-x  0.797
2014 Ovsyannikova IG, Pankratz VS, Larrabee BR, Jacobson RM, Poland GA. HLA genotypes and rubella vaccine immune response: additional evidence. Vaccine. 32: 4206-13. PMID 24837503 DOI: 10.1016/j.vaccine.2014.04.091  0.771
2014 Poland GA, Ovsyannikova IG, Kennedy RB, Lambert ND, Kirkland JL. A systems biology approach to the effect of aging, immunosenescence and vaccine response. Current Opinion in Immunology. 29: 62-8. PMID 24820347 DOI: 10.1016/J.Coi.2014.04.005  0.833
2014 Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients. Immunogenetics. 66: 493-9. PMID 24811271 DOI: 10.1007/s00251-014-0776-3  0.792
2014 Ovsyannikova IG, White SJ, Albrecht RA, García-Sastre A, Poland GA. Turkey versus guinea pig red blood cells: Hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1 Viral Immunology. 27: 174-178. PMID 24787023 DOI: 10.1089/vim.2013.0111  0.556
2014 Pondo T, Rose CE, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine. 32: 3548-54. PMID 24768633 DOI: 10.1016/j.vaccine.2014.04.025  0.467
2014 Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Review of Vaccines. 13: 657-69. PMID 24702429 DOI: 10.1586/14760584.2014.905744  0.795
2014 Painter SD, Haralambieva IH, Ovsyannikova IG, Grill DE, Poland GA. Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay. Viral Immunology. 27: 32-8. PMID 24605786 DOI: 10.1089/vim.2013.0099  0.683
2014 Haralambieva IH, Salk HM, Lambert ND, Ovsyannikova IG, Kennedy RB, Warner ND, Pankratz VS, Poland GA. Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts. Vaccine. 32: 1946-53. PMID 24530932 DOI: 10.1016/j.vaccine.2014.01.090  0.839
2014 Lambert ND, Pankratz VS, Larrabee BR, Ogee-Nwankwo A, Chen MH, Icenogle JP, Poland GA. High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers. Clinical and Vaccine Immunology : Cvi. 21: 340-6. PMID 24391140 DOI: 10.1128/CVI.00681-13  0.477
2014 Lambert ND, Haralambieva IH, Ovsyannikova IG, Larrabee BR, Pankratz VS, Poland GA. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts. Immunologic Research. 58: 1-8. PMID 24375276 DOI: 10.1007/s12026-013-8475-y  0.779
2014 Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, et al. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. Vaccine. 32: 1019-28. PMID 24373307 DOI: 10.1016/j.vaccine.2013.10.039  0.402
2014 Ovsyannikova IG, White SJ, Larrabee BR, Grill DE, Jacobson RM, Poland GA. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals Vaccine. 32: 881-887. PMID 24360890 DOI: 10.1016/j.vaccine.2013.12.009  0.737
2013 McKinney BA, White BC, Grill DE, Li PW, Kennedy RB, Poland GA, Oberg AL. ReliefSeq: a gene-wise adaptive-K nearest-neighbor feature selection tool for finding gene-gene interactions and main effects in mRNA-Seq gene expression data. Plos One. 8: e81527. PMID 24339943 DOI: 10.1371/journal.pone.0081527  0.483
2013 Fridley BL, Jenkins GD, Grill DE, Kennedy RB, Poland GA, Oberg AL. Soft truncation thresholding for gene set analysis of RNA-seq data: application to a vaccine study. Scientific Reports. 3: 2898. PMID 24104466 DOI: 10.1038/Srep02898  0.623
2013 Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity. Journal of Immunological Methods. 398: 44-50. PMID 24055591 DOI: 10.1016/j.jim.2013.09.007  0.74
2013 Morgan AJ, Poland GA. Edward Jenner and the discovery of vaccination--an appeal for the Edward Jenner Museum. Vaccine. 31: 4933-4. PMID 23911851 DOI: 10.1016/j.vaccine.2013.07.046  0.566
2013 Ovsyannikova IG, Haralambieva IH, Kennedy RB, O'Byrne MM, Pankratz VS, Poland GA. Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship. The Journal of Infectious Diseases. 208: 1422-30. PMID 23901078 DOI: 10.1093/infdis/jit341  0.802
2013 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA. Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals. Human Immunology. 74: 1263-6. PMID 23806267 DOI: 10.1016/j.humimm.2013.06.031  0.76
2013 Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, Jacobson RM, Oberg AL. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Seminars in Immunology. 25: 89-103. PMID 23755893 DOI: 10.1016/j.smim.2013.04.007  0.829
2013 Haralambieva IH, Oberg AL, Ovsyannikova IG, Kennedy RB, Grill DE, Middha S, Bot BM, Wang VW, Smith DI, Jacobson RM, Poland GA. Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. Plos One. 8: e62149. PMID 23658707 DOI: 10.1371/Journal.Pone.0062149  0.786
2013 Ovsyannikova IG, Pankratz VS, Vierkant RA, Pajewski NM, Quinn CP, Kaslow RA, Jacobson RM, Poland GA. Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed. Infection and Immunity. 81: 2584-91. PMID 23649091 DOI: 10.1128/Iai.00269-13  0.661
2013 Patel AR, Zietlow J, Jacobson RM, Poland GA, Juhn YJ. Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Primary Care Respiratory Journal : Journal of the General Practice Airways Group. 22: 278-83. PMID 23636585 DOI: 10.4104/pcrj.2013.00039  0.38
2013 Poland GA, Poland CM, Howe CL. Influenza vaccine and Guillain-Barré syndrome: making informed decisions. Lancet (London, England). 381: 1437-9. PMID 23622271 DOI: 10.1016/S0140-6736(13)60182-8  0.4
2013 Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine. 31: A1-20. PMID 23587330 DOI: 10.1016/j.vaccine.2013.02.033  0.565
2013 Poland GA, Schaffner W, Hopkins RH, US Department of Health and Human Services. Immunization guidelines in the United States: new vaccines and new recommendations for children, adolescents, and adults. Vaccine. 31: 4689-93. PMID 23583896 DOI: 10.1016/j.vaccine.2013.03.031  0.395
2013 Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Poland GA. Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity. Human Immunology. 74: 768-74. PMID 23416095 DOI: 10.1016/j.humimm.2013.01.031  0.646
2013 White SJ, Taylor MJ, Hurt RT, Jensen MD, Poland GA. Leptin-based adjuvants: An innovative approach to improve vaccine response Vaccine. 31: 1666-1672. PMID 23370154 DOI: 10.1016/j.vaccine.2013.01.032  0.578
2013 Haralambieva IH, Ovsyannikova IG, Pankratz VS, Kennedy RB, Jacobson RM, Poland GA. The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Review of Vaccines. 12: 57-70. PMID 23256739 DOI: 10.1586/erv.12.134  0.848
2013 Ofstead CL, Sherman BW, Wetzler HP, Dirlam Langlay AM, Mueller NJ, Ward JM, Ritter DR, Poland GA. Effectiveness of worksite interventions to increase influenza vaccination rates among employees and families. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 156-63. PMID 23047659 DOI: 10.1097/JOM.0b013e3182717d13  0.434
2012 Tao C, He Y, Yang H, Poland GA, Chute CG. Ontology-based time information representation of vaccine adverse events in VAERS for temporal analysis. Journal of Biomedical Semantics. 3: 13. PMID 23256916 DOI: 10.1186/2041-1480-3-13  0.444
2012 Ovsyannikova IG, Haralambieva IH, Kennedy RB, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination. Gene. 510: 59-65. PMID 23009887 DOI: 10.1016/j.gene.2012.08.021  0.728
2012 Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Review of Vaccines. 11: 985-94. PMID 23002979 DOI: 10.1586/erv.12.61  0.712
2012 Talbot TR, Babcock H, Cotton D, Maragakis LL, Poland GA, Septimus EJ, Tapper ML, Weber DJ. The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA). Infection Control and Hospital Epidemiology. 33: 981-3. PMID 22961016 DOI: 10.1086/667772  0.423
2012 Haralambieva IH, Oberg AL, Dhiman N, Ovsyannikova IG, Kennedy RB, Grill DE, Jacobson RM, Poland GA. High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. The Journal of Infectious Diseases. 206: 1512-20. PMID 22949304 DOI: 10.1093/infdis/jis546  0.827
2012 Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM. Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 30: 5875-9. PMID 22814409 DOI: 10.1016/j.vaccine.2012.06.076  0.43
2012 Taylor MJ, Haralambieva IH, Vierkant RA, Ovsyannikova IG, Poland GA. Response surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells. Journal of Immunological Methods. 382: 220-3. PMID 22705088 DOI: 10.1016/j.jim.2012.06.004  0.631
2012 Wicker S, Poland GA. Measles vaccination in health care personnel: mandates, ethics, and patient safety. Vaccine. 30: 4407-8. PMID 22682707 DOI: 10.1016/j.vaccine.2012.05.015  0.368
2012 Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Jacobson RM, Poland GA. Genome-wide genetic associations with IFNγ response to smallpox vaccine. Human Genetics. 131: 1433-51. PMID 22661280 DOI: 10.1007/s00439-012-1179-x  0.781
2012 Pajewski NM, Shrestha S, Quinn CP, Parker SD, Wiener H, Aissani B, McKinney BA, Poland GA, Edberg JC, Kimberly RP, Tang J, Kaslow RA. A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed. Vaccine. 30: 4778-84. PMID 22658931 DOI: 10.1016/J.Vaccine.2012.05.032  0.51
2012 Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Poland GA. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Human Genetics. 131: 1403-21. PMID 22610502 DOI: 10.1007/s00439-012-1174-2  0.79
2012 Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine. 30: 4182-9. PMID 22542470 DOI: 10.1016/j.vaccine.2012.04.055  0.737
2012 White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles, mumps, and rubella. Clinical Obstetrics and Gynecology. 55: 550-9. PMID 22510638 DOI: 10.1097/GRF.0b013e31824df256  0.401
2012 White SJ, Haralambieva IH, Ovsyannikova IG, Vierkant RA, O'Byrne MM, Poland GA. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes. Human Immunology. 73: 636-40. PMID 22504412 DOI: 10.1016/j.humimm.2012.03.015  0.528
2012 Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2911-8. PMID 22490782 DOI: 10.1096/Fj.11-190017  0.723
2012 Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Independence of measles-specific humoral and cellular immune responses to vaccination. Human Immunology. 73: 474-9. PMID 22406060 DOI: 10.1016/j.humimm.2012.02.016  0.771
2012 Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine. 30: 2146-52. PMID 22285888 DOI: 10.1016/j.vaccine.2012.01.038  0.747
2012 Kennedy RB, Ovsyannikova IG, Haralambieva IH, O'Byrne MM, Jacobson RM, Pankratz VS, Poland GA. Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine. 30: 2159-67. PMID 22265947 DOI: 10.1016/j.vaccine.2012.01.025  0.836
2012 Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunology. 25: 29-36. PMID 22239234 DOI: 10.1089/vim.2011.0051  0.788
2012 Vermeulen JN, Lange JM, Tyring SK, Peters PH, Nunez M, Poland G, Levin MJ, Freeman C, Chalikonda I, Li J, Smith JG, Caulfield MJ, Stek JE, Chan IS, Vessey R, et al. Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vaccine. 30: 904-10. PMID 22154769 DOI: 10.1016/j.vaccine.2011.11.096  0.45
2012 Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine. Pharmacogenetics and Genomics. 22: 20-31. PMID 22082653 DOI: 10.1097/FPC.0b013e32834df186  0.641
2012 Umlauf BJ, Pinsky NA, Ovsyannikova IG, Poland GA. Detection of vaccinia virus-specific IFNγ and IL-10 secretion from human PBMCs and CD8⁺ T cells by ELISPOT. Methods in Molecular Biology (Clifton, N.J.). 792: 199-218. PMID 21956512 DOI: 10.1007/978-1-61779-325-7_16  0.727
2011 Morgan AJ, Poland GA. The Jenner Society and the Edward Jenner Museum: tributes to a physician-scientist. Vaccine. 29: D152-4. PMID 22486976 DOI: 10.1016/j.vaccine.2011.08.128  0.39
2011 Poland GA, Kennedy RB, Ovsyannikova IG. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? Plos Pathogens. 7: e1002344. PMID 22241978 DOI: 10.1371/journal.ppat.1002344  0.806
2011 Henriksen Hellyer JM, DeVries AS, Jenkins SM, Lackore KA, James KM, Ziegenfuss JY, Poland GA, Tilburt JC. Attitudes toward and uptake of H1N1 vaccine among health care workers during the 2009 H1N1 pandemic. Plos One. 6: e29478. PMID 22216290 DOI: 10.1371/journal.pone.0029478  0.391
2011 Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Human Heredity. 72: 206-23. PMID 22086389 DOI: 10.1159/000331585  0.585
2011 Maltezou HC, Wicker S, Borg M, Heininger U, Puro V, Theodoridou M, Poland GA. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 29: 9557-62. PMID 21964058 DOI: 10.1016/j.vaccine.2011.09.076  0.472
2011 Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunology. 24: 415-20. PMID 21958369 DOI: 10.1089/vim.2011.0029  0.776
2011 Haralambieva IH, Ovsyannikova IG, Umlauf BJ, Vierkant RA, Shane Pankratz V, Jacobson RM, Poland GA. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine. 29: 8988-97. PMID 21939710 DOI: 10.1016/j.vaccine.2011.09.043  0.682
2011 Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine. 29: 7883-95. PMID 21875636 DOI: 10.1016/j.vaccine.2011.08.083  0.823
2011 Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose. Vaccine. 29: 7982-91. PMID 21872631 DOI: 10.1016/j.vaccine.2011.08.060  0.676
2011 Kennedy RB, Poland GA. The top five "game changers" in vaccinology: toward rational and directed vaccine development. Omics : a Journal of Integrative Biology. 15: 533-7. PMID 21815811 DOI: 10.1089/omi.2011.0012  0.747
2011 Haralambieva IH, Ovsyannikova IG, Dhiman N, Kennedy RB, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA. Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans. The Journal of Infectious Diseases. 204: 433-41. PMID 21742843 DOI: 10.1093/infdis/jir268  0.837
2011 Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. Omics : a Journal of Integrative Biology. 15: 625-36. PMID 21732819 DOI: 10.1089/omi.2011.0032  0.829
2011 Ovsyannikova IG, Poland GA. Vaccinomics: current findings, challenges and novel approaches for vaccine development. The Aaps Journal. 13: 438-44. PMID 21671143 DOI: 10.1208/s12248-011-9281-x  0.788
2011 Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. The Journal of Infectious Diseases. 203: 1546-55. PMID 21592983 DOI: 10.1093/infdis/jir167  0.762
2011 Oberg AL, Kennedy RB, Li P, Ovsyannikova IG, Poland GA. Systems biology approaches to new vaccine development. Current Opinion in Immunology. 23: 436-43. PMID 21570272 DOI: 10.1016/j.coi.2011.04.005  0.77
2011 Haralambieva IH, Ovsyannikova IG, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine. 29: 4485-91. PMID 21539880 DOI: 10.1016/j.vaccine.2011.04.037  0.716
2011 Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Human Genetics. 130: 547-61. PMID 21424379 DOI: 10.1007/s00439-011-0977-x  0.714
2011 Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. The Journal of Infectious Diseases. 203: 666-73. PMID 21282194 DOI: 10.1093/Infdis/Jiq093  0.434
2011 Oberg AL, Dhiman N, Grill DE, Ryan JE, Kennedy RB, Poland GA. Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays. Journal of Immunological Methods. 366: 69-78. PMID 21277306 DOI: 10.1016/j.jim.2011.01.011  0.672
2011 Ottenberg AL, Wu JT, Poland GA, Jacobson RM, Koenig BA, Tilburt JC. Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate. American Journal of Public Health. 101: 212-6. PMID 21228284 DOI: 10.2105/AJPH.2009.190751  0.417
2011 Haralambieva IH, Ovsyannikova IG, Dhiman N, Vierkant RA, Jacobson RM, Poland GA. Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene. Journal of Medical Virology. 82: 1966-75. PMID 20872725 DOI: 10.1002/jmv.21899  0.563
2010 Yoo KH, Agarwal K, Butterfield M, Jacobson RM, Poland GA, Juhn YJ. Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 31: 499-506. PMID 21708062 DOI: 10.2500/aap.2010.31.3399  0.427
2010 Kennedy RB, Poland GA. The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins. Virology. 408: 232-40. PMID 20961593 DOI: 10.1016/j.virol.2010.09.013  0.725
2010 Pankratz VS, Vierkant RA, O'Byrne MM, Ovsyannikova IG, Poland GA. Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment. Bmc Immunology. 11: 48. PMID 20923569 DOI: 10.1186/1471-2172-11-48  0.716
2010 Sullivan SJ, Jacobson R, Poland GA. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Review of Vaccines. 9: 1127-33. PMID 20923264 DOI: 10.1586/erv.10.117  0.521
2010 Talbot TR, Babcock H, Caplan AL, Cotton D, Maragakis LL, Poland GA, Septimus EJ, Tapper ML, Weber DJ. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infection Control and Hospital Epidemiology. 31: 987-95. PMID 20807037 DOI: 10.1086/656558  0.541
2010 Wicker S, Marckmann G, Poland GA, Rabenau HF. Healthcare workers' perceptions of mandatory vaccination: results of an anonymous survey in a German University Hospital. Infection Control and Hospital Epidemiology. 31: 1066-9. PMID 20804415 DOI: 10.1086/656242  0.543
2010 Greenwood NP, Ovsyannikova IG, Vierkant RA, O'Byrne MM, Poland GA. A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays Viral Immunology. 23: 353-357. PMID 20712479 DOI: 10.1089/vim.2010.0026  0.52
2010 Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. Plos One. 5: e11806. PMID 20668555 DOI: 10.1371/journal.pone.0011806  0.678
2010 Rhudy LM, Tucker SJ, Ofstead CL, Poland GA. Personal choice or evidence-based nursing intervention: nurses' decision-making about influenza vaccination. Worldviews On Evidence-Based Nursing / Sigma Theta Tau International, Honor Society of Nursing. 7: 111-20. PMID 20367806 DOI: 10.1111/J.1741-6787.2010.00190.X  0.416
2010 Dhiman N, Haralambieva IH, Kennedy RB, Vierkant RA, O'Byrne MM, Ovsyannikova IG, Jacobson RM, Poland GA. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics. 62: 197-210. PMID 20217072 DOI: 10.1007/s00251-010-0423-6  0.787
2010 Dhiman N, Haralambieva IH, Vierkant RA, Pankratz VS, Ryan JE, Jacobson RM, Ovsyannikova IG, Poland GA. Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine. 50: 24-9. PMID 20117947 DOI: 10.1016/j.cyto.2009.12.002  0.661
2010 Haralambieva IH, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Human Immunology. 71: 383-91. PMID 20079393 DOI: 10.1016/j.humimm.2010.01.004  0.67
2010 Ovsyannikova IG, Haralambieva IH, Dhiman N, O'Byrne MM, Pankratz VS, Jacobson RM, Poland GA. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. The Journal of Infectious Diseases. 201: 207-13. PMID 20001730 DOI: 10.1086/649588  0.762
2010 Tosh PK, Kennedy RB, Vierkant RA, Jacobson RM, Poland GA. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity. Viral Immunology. 22: 451-6. PMID 19951182 DOI: 10.1089/vim.2009.0068  0.705
2009 Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Human Genetics. 127: 207-21. PMID 19902255 DOI: 10.1007/s00439-009-0763-1  0.668
2009 Kennedy RB, Ovsyannikova IG, Vierkant RA, Jacobson RM, Poland GA. Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses. Human Immunology. 71: 128-35. PMID 19896518 DOI: 10.1016/j.humimm.2009.11.002  0.773
2009 Sullivan SJ, Jacobson R, Poland GA. Mandating influenza vaccination for healthcare workers. Expert Review of Vaccines. 8: 1469-74. PMID 19863238 DOI: 10.1586/erv.09.118  0.516
2009 Kennedy RB, Ovsyannikova I, Poland GA. Smallpox vaccines for biodefense. Vaccine. D73-9. PMID 19837292 DOI: 10.1016/j.vaccine.2009.07.103  0.799
2009 Johnson KL, Ovsyannikova IG, Mason CJ, Bergen HR, Poland GA. Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. Vaccine. 28: 38-47. PMID 19822231 DOI: 10.1016/j.vaccine.2009.09.126  0.58
2009 Ovsyannikova IG, Jacobson RM, Vierkant RA, O'Byrne MM, Poland GA. Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine. 27: 6926-31. PMID 19761839 DOI: 10.1016/j.vaccine.2009.08.109  0.691
2009 Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 817-40. PMID 19659433 DOI: 10.1086/605430  0.585
2009 Kennedy R, Pankratz VS, Swanson E, Watson D, Golding H, Poland GA. Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay. Clinical and Vaccine Immunology : Cvi. 16: 1105-12. PMID 19535540 DOI: 10.1128/CVI.00109-09  0.657
2009 Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA. The immunology of smallpox vaccines. Current Opinion in Immunology. 21: 314-20. PMID 19524427 DOI: 10.1016/j.coi.2009.04.004  0.84
2009 Poland GA, Mulligan MJ. The imperative of influenza vaccines for elderly individuals-an evolving story. The Journal of Infectious Diseases. 200: 161-3. PMID 19508160 DOI: 10.1086/599791  0.371
2009 Poland G, Barrett A. The old and the new: successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century. Current Opinion in Immunology. 21: 305-307. PMID 19500965 DOI: 10.1016/J.Coi.2009.05.014  0.543
2009 Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals--a review of studies on attitudes and predictors. Vaccine. 27: 3935-44. PMID 19467744 DOI: 10.1016/j.vaccine.2009.03.056  0.539
2009 Jacobson RM, Ovsyannikova IG, Poland GA. Testing vaccines in pediatric research subjects. Vaccine. 27: 3291-4. PMID 19460598 DOI: 10.1016/j.vaccine.2009.02.031  0.642
2009 Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. Pharmacogenomics. 10: 837-52. PMID 19450131 DOI: 10.2217/pgs.09.25  0.794
2009 Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. The Pediatric Infectious Disease Journal. 28: 431-2. PMID 19395950 DOI: 10.1097/INF.0b013e3181a6a511  0.679
2009 Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1254-6. PMID 19323631 DOI: 10.1086/598989  0.568
2009 Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine. D35-40. PMID 19230157 DOI: 10.1016/j.vaccine.2008.07.065  0.793
2009 Ovsyannikova IG, Ryan JE, Vierkant RA, O'Byrne MM, Pankratz VS, Jacobson RM, Poland GA. Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine. 27: 3359-66. PMID 19200845 DOI: 10.1016/j.vaccine.2009.01.079  0.706
2009 Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine. 27: 3240-4. PMID 19200833 DOI: 10.1016/j.vaccine.2009.01.069  0.707
2009 Ovsyannikova IG, Vierkant RA, Pankratz VS, O'Byrne MM, Jacobson RM, Poland GA. HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. Vaccine. 27: 3349-58. PMID 19200828 DOI: 10.1016/j.vaccine.2009.01.080  0.684
2009 Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, Poland GA. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 27: 3319-23. PMID 19200827 DOI: 10.1016/j.vaccine.2009.01.086  0.818
2009 Poland GA, Ovsyannikova IG, Jacobson RM. Personalized vaccines: the emerging field of vaccinomics. Expert Opinion On Biological Therapy. 8: 1659-67. PMID 18847302 DOI: 10.1517/14712598.8.11.1659  0.751
2008 Tilburt JC, Mueller PS, Ottenberg AL, Poland GA, Koenig BA. Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics. Vaccine. 26: D27-30. PMID 19230155 DOI: 10.1016/j.vaccine.2008.07.068  0.516
2008 Ryan JE, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. Journal of Immunological Methods. 341: 97-105. PMID 19038260 DOI: 10.1016/j.jim.2008.11.001  0.676
2008 Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine. 26: 6183-8. PMID 18598732 DOI: 10.1016/j.vaccine.2008.06.057  0.791
2008 Poland GA, Johnson DR. Increasing influenza vaccination rates: the need to vaccinate throughout the entire influenza season. The American Journal of Medicine. 121: S3-10. PMID 18589066 DOI: 10.1016/j.amjmed.2008.05.002  0.569
2008 Haralambieva IH, Ovsyannikova IG, Vierkant RA, Poland GA. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clinical and Vaccine Immunology : Cvi. 15: 1054-9. PMID 18463223 DOI: 10.1128/CVI.00008-08  0.621
2008 Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics. 121: e1091-9. PMID 18450852 DOI: 10.1542/peds.2007-1575  0.803
2008 Kasten MJ, Poland GA. Influenza vaccination and the elderly: pandemic preparedness. Drugs & Aging. 25: 179-86. PMID 18331070  0.512
2008 Dhiman N, Ovsyannikova IG, Vierkant RA, Ryan JE, Pankratz VS, Jacobson RM, Poland GA. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine. 26: 1731-6. PMID 18325643 DOI: 10.1016/j.vaccine.2008.01.017  0.696
2008 Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, et al. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: S271-93. PMID 18284368 DOI: 10.1086/524750  0.562
2008 Neff J, Modlin J, Birkhead GS, Poland G, Robertson RM, Sepkowitz K, Yancy C, Gardner P, Gray GC, Maurer T, Siegel J, Guerra FA, Berger T, Flanders WD, Shope R, et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: S258-70. PMID 18284367 DOI: 10.1086/524749  0.521
2008 Tucker SJ, Poland GA, Jacobson RM. Requiring influenza vaccination for health care workers American Journal of Nursing. 108: 32-34. PMID 18227666 DOI: 10.1097/01.NAJ.0000310328.47809.d4  0.422
2008 Poland GA, Ofstead CL, Tucker SJ, Beebe TJ. Receptivity to mandatory influenza vaccination policies for healthcare workers among registered nurses working on inpatient units Infection Control and Hospital Epidemiology. 29: 170-173. PMID 18179373 DOI: 10.1086/526432  0.446
2008 Ofstead CL, Tucker SJ, Beebe TJ, Poland GA. Influenza vaccination among registered nurses: Information receipt, knowledge, and decision-making at an institution with a multifaceted educational program Infection Control and Hospital Epidemiology. 29: 99-106. PMID 18179363 DOI: 10.1086/526431  0.524
2008 St Sauver JL, Jacobsen SJ, Jacobson RM, Vierkant RA, Ovsyannikova IG, Dhiman N, Poland GA. Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. Paediatric and Perinatal Epidemiology. 21: 376-84. PMID 17564596 DOI: 10.1111/j.1365-3016.2007.00822.x  0.645
2007 Targonski PV, Poland GA. Pneumococcal vaccination in adults: recommendations, trends, and prospects. Cleveland Clinic Journal of Medicine. 74: 401-6, 408-10, 413-4. PMID 17569198  0.494
2007 Dhiman N, Poland GA, Cunningham JM, Jacobson RM, Ovsyannikova IG, Vierkant RA, Wu Y, Pankratz VS. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. The Journal of Allergy and Clinical Immunology. 120: 666-72. PMID 17560639 DOI: 10.1016/j.jaci.2007.04.036  0.689
2007 Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses. Virology. 364: 87-94. PMID 17397893 DOI: 10.1016/j.virol.2007.02.028  0.625
2007 Jacobson RM, Targonski PV, Poland GA. Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases. Vaccine. 25: 3165-9. PMID 17292516 DOI: 10.1016/j.vaccine.2007.01.049  0.458
2007 Jacobson RM, Targonski PV, Poland GA. A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine. 25: 3146-52. PMID 17292515 DOI: 10.1016/j.vaccine.2007.01.046  0.442
2007 Jacobson RM, Targonski PV, Poland GA. Meta-analyses in vaccinology. Vaccine. 25: 3153-9. PMID 17291639 DOI: 10.1016/j.vaccine.2007.01.047  0.404
2007 Poland GA, Jacobson RM, Targonski PV. Avian and pandemic influenza: an overview. Vaccine. 25: 3057-61. PMID 17289227 DOI: 10.1016/j.vaccine.2007.01.050  0.318
2007 Jacobson RM, Ovsyannikova IG, Targonski PV, Poland GA. Studies of twins in vaccinology. Vaccine. 25: 3160-4. PMID 17284336 DOI: 10.1016/j.vaccine.2007.01.048  0.735
2007 Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine. 25: 3090-100. PMID 17280755 DOI: 10.1016/j.vaccine.2007.01.020  0.759
2007 Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine. 25: 3066-9. PMID 17275144 DOI: 10.1016/j.vaccine.2007.01.025  0.53
2007 Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect? Cytokine. 36: 173-9. PMID 17234427 DOI: 10.1016/j.cyto.2006.12.001  0.595
2007 Tyring SK, Diaz-Mitoma F, Padget LG, Nunez M, Poland G, Cassidy WM, Bundick ND, Li J, Chan IS, Stek JE, Annunziato PW. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age. Vaccine. 25: 1877-83. PMID 17227688 DOI: 10.1016/J.Vaccine.2006.10.027  0.47
2007 Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, Poland GA. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clinical and Vaccine Immunology : Cvi. 14: 115-22. PMID 17215337 DOI: 10.1128/CVI.00247-06  0.707
2007 Kennedy R, Poland GA. T-Cell epitope discovery for variola and vaccinia viruses. Reviews in Medical Virology. 17: 93-113. PMID 17195963 DOI: 10.1002/rmv.527  0.695
2006 Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, Poland GA, Jacobson RM. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. The Journal of Infectious Diseases. 195: 21-9. PMID 17152005 DOI: 10.1086/510596  0.827
2006 Juhn YJ, Kita H, Lee LA, Swanson RJ, Smith R, Bagniewski SM, Weaver AL, Pankratz VS, Jacobson RM, Poland GA. Childhood asthma and measles vaccine response. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 97: 469-76. PMID 17069101 DOI: 10.1016/S1081-1206(10)60937-4  0.456
2006 Ovsyannikova IG, Vierkant RA, Poland GA. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides. Vaccine. 24: 5381-9. PMID 16714073 DOI: 10.1016/j.vaccine.2006.04.034  0.596
2006 Dhiman N, Ovsyannikova IG, Oberg AL, Grill DE, Jacobson RM, Poland GA. Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study. Human Immunology. 66: 1125-36. PMID 16571413 DOI: 10.1016/j.humimm.2005.10.002  0.783
2006 Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. The Journal of Infectious Diseases. 193: 655-63. PMID 16453260 DOI: 10.1086/500144  0.728
2006 Ovsyannikova IG, Dhiman N, Jacobson RM, Poland GA. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Review of Vaccines. 5: 33-43. PMID 16451106 DOI: 10.1586/14760584.5.1.33  0.786
2005 Johnson KL, Ovsyannikova IG, Poland GA, Muddiman DC. Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry. Journal of Proteome Research. 4: 2243-9. PMID 16335972 DOI: 10.1021/pr0501416  0.565
2005 Ovsyannikova IG, Ryan JE, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics. 57: 828-36. PMID 16331510 DOI: 10.1007/s00251-005-0061-6  0.72
2005 Johnson KL, Ovsyannikova IG, Madden BJ, Poland GA, Muddiman DC. Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus. Journal of the American Society For Mass Spectrometry. 16: 1812-7. PMID 16185891 DOI: 10.1016/j.jasms.2005.07.015  0.503
2005 St Sauver JL, Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. Human Immunology. 66: 788-98. PMID 16112026 DOI: 10.1016/j.humimm.2005.03.008  0.712
2005 Ryan JE, Ovsyannikova IG, Poland GA. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Methods in Molecular Biology (Clifton, N.J.). 302: 207-18. PMID 15937354 DOI: 10.1385/1-59259-903-6:207  0.62
2005 Poland GA, Jacobson RM, Koutsky LA, Tamms GM, Railkar R, Smith JF, Bryan JT, Cavanaugh PF, Jansen KU, Barr E. Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial. Mayo Clinic Proceedings. 80: 601-10. PMID 15887427 DOI: 10.4065/80.5.601  0.403
2005 Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clinical Immunology (Orlando, Fla.). 115: 154-61. PMID 15885638 DOI: 10.1016/j.clim.2004.12.010  0.773
2005 Ovsyannikova IG, Johnson KL, Naylor S, Poland GA. Identification of HLA-DRB1-bound self-peptides following measles virus infection. Journal of Immunological Methods. 297: 153-67. PMID 15777939 DOI: 10.1016/j.jim.2004.12.020  0.55
2005 Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine. 23: 2078-81. PMID 15755574 DOI: 10.1016/j.vaccine.2005.01.012  0.499
2005 Ovsyannikova IG, Jacobson RM, Ryan JE, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics. 56: 798-807. PMID 15712014 DOI: 10.1007/s00251-004-0756-0  0.694
2005 Raman SV, Jacobson RM, Poland GA. A parent-driven, computer-based vaccine information system: addressing variability in information needs for the varicella vaccine. Mayo Clinic Proceedings. 80: 187-92. PMID 15704773 DOI: 10.4065/80.2.187  0.45
2005 Howe RC, Ovsyannikova IG, Pinsky NA, Poland GA. Identification of Th0 cells responding to measles virus. Human Immunology. 66: 104-15. PMID 15694995 DOI: 10.1016/j.humimm.2004.10.007  0.538
2005 Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. The Journal of Infectious Diseases. 191: 515-9. PMID 15655774 DOI: 10.1086/427558  0.731
2005 Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Human Immunology. 65: 1506-15. PMID 15603879 DOI: 10.1016/j.humimm.2004.07.001  0.706
2004 Boyce TG, Weaver AL, St Sauver JL, Woodward-Lee AE, Stancl JK, Park JY, Jacobsen SJ, Jacobson RM, Poland GA. Pertussis vaccination and the risk of respiratory syncytial virus-associated hospitalization. The Pediatric Infectious Disease Journal. 23: 897-901. PMID 15602187  0.423
2004 Poland G, Ovsyannikova IG, Jones RT, Yunginger JW. Latex allergens are not detectable in reconstituted smallpox vaccine or vaccine vial stoppers. The Journal of Allergy and Clinical Immunology. 114: 454-6. PMID 15341028  0.743
2004 Ovsyannikova IG, Jacobson RM, Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics. 5: 417-27. PMID 15165177 DOI: 10.1517/14622416.5.4.417  0.795
2004 Ovsyannikova IG, Jacobson RM, Vierkant RA, Shane Pankratz V, Jacobsen SJ, Poland GA. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine. 22: 1914-20. PMID 15121303 DOI: 10.1016/j.vaccine.2003.11.016  0.696
2004 Dhiman N, Ovsyannikova IG, Howe RC, Ryan JE, Jacobson RM, Poland GA. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. Journal of Immunological Methods. 287: 217-25. PMID 15099769 DOI: 10.1016/j.jim.2004.02.002  0.565
2004 Targonski PV, Poland GA. Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly? Drugs & Aging. 21: 349-59. PMID 15084138  0.525
2004 Ovsyannikova IG, Poland GA, Easler NJ, Vierkant RA. Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals. Human Immunology. 65: 209-17. PMID 15041159 DOI: 10.1016/j.humimm.2003.12.002  0.6
2004 Smith SA, Poland GA. Influenza and pneumococcal immunization in diabetes. Diabetes Care. 27: S111-3. PMID 14693944  0.3
2004 Ovsyannikova IG, Johnson KL, Muddiman DC, Vierkant RA, Poland GA. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. Journal of Virology. 78: 42-51. PMID 14671086 DOI: 10.1128/JVI.78.1.42-51.2004  0.618
2004 Ovsyannikova IG, Reid KC, Jacobson RM, Oberg AL, Klee GG, Poland GA. Cytokine production patterns and antibody response to measles vaccine. Vaccine. 21: 3946-53. PMID 12922130 DOI: 10.1016/s0264-410x(03)00272-x  0.648
2004 St Sauver JL, Schaid DJ, Vierkant RA, Jacobson RM, Jacobsen SJ, Ovsyannikova IG, Poland GA. Associations between measles antibody levels and the protein structure of class II human leukocyte antigens. Human Immunology. 64: 696-707. PMID 12826372 DOI: 10.1016/s0198-8859(03)00087-9  0.54
2004 Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clinical and Diagnostic Laboratory Immunology. 10: 411-6. PMID 12738640 DOI: 10.1128/cdli.10.3.411-416.2003  0.725
2003 Poland GA, Neff JM. Smallpox vaccine: problems and prospects. Immunology and Allergy Clinics of North America. 23: 731-43. PMID 14753389 DOI: 10.1016/S0889-8561(03)00096-1  0.567
2003 Rottinghaus ST, Poland GA, Jacobson RM, Barr LJ, Roy MJ. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine. 21: 4604-8. PMID 14575774  0.565
2003 Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. The American Journal of Gastroenterology. 98: 2289-92. PMID 14572581 DOI: 10.1111/j.1572-0241.2003.07701.x  0.437
2003 Ovsyannikova IG, Johnson KL, Naylor S, Muddiman DC, Poland GA. Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood. Virology. 312: 495-506. PMID 12919753  0.614
2003 Jacobson RM, Zabel KS, Poland GA. The overall safety profile of currently available vaccines directed against infectious diseases. Expert Opinion On Drug Safety. 2: 215-23. PMID 12904101 DOI: 10.1517/14740338.2.3.215  0.473
2003 Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, Gray GC, Ostroff S, Eckart RE, Hospenthal DR, Gibson RL, Grabenstein JD, Arness MK, Tornberg DN. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. Jama. 289: 3283-9. PMID 12824210 DOI: 10.1001/Jama.289.24.3283  0.437
2003 Jacobson RM, Poland GA, Vierkant RA, Pankratz VS, Schaid DJ, Jacobsen SJ, Sauver JS, Moore SB. The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Human Immunology. 64: 103-9. PMID 12507820  0.454
2002 Jacobson RM, Zabel KS, Poland GA. The challenge of vaccine safety. Seminars in Pediatric Infectious Diseases. 13: 215-20. PMID 12199618 DOI: 10.1053/spid.2002.125865  0.503
2002 Poland GA, Murray D, Bonilla-Guerrero R. New vaccine development. Bmj (Clinical Research Ed.). 324: 1315-9. PMID 12039828 DOI: 10.1136/bmj.324.7349.1315  0.531
2002 St Sauver JL, Ovsyannikova IG, Jacobson RM, Jacobsen SJ, Vierkant RA, Schaid DJ, Pankratz VS, Green EM, Poland GA. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. The Journal of Infectious Diseases. 185: 1545-9. PMID 12023759 DOI: 10.1086/340573  0.712
2002 St Sauver JL, Jacobson RM, Vierkant RA, Jacobsen SJ, Green EM, Poland GA. Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn. Mayo Clinic Proceedings. 77: 241-5. PMID 11888027  0.415
Show low-probability matches.